Abstract Submission Period
- April 17(Thu.), 2025 –
June 5(Thu.) , 2025 JST
Extended until June 12 (Thu.) , 2025 JST
Extended until June 19 (Thu.) , 2025 JST
※There are no plans to extend the abstract submission
deadline any further.
Abstract submission has been closed.
Submission Requirements
- Those who wish to submit abstracts for this meeting must complete your registration before the abstract submission.If you have not registered yet, please visit the Online Registration page first.
- The first and presenting author must be a member of the Japanese Society for Virology (JSV). Non-members who wish to submit abstracts should join JSV first.
- JSV membership is not necessarily required for those who belong to overseas facilities.
- International students in Japan should apply for JSV membership if they wish to submit abstracts.
- The JSV membership number is required when you submit an abstract. Please put “99999” if you are in the process of applying for membership.
- JSV membership application can be accessed from the website of The Japanese Society for Virology.
- 【Inquiry about JSV membership】
- The Japanese Society for Virology
- c/o Microbiological Science, Inc.
- 4-13-18 Koishikawa, Bunkyo-ku, Tokyo 112-0002, Japan
- E-mail: biseibutsu-com@umin.ac.jp
Presentation Style/Language
- Oral
- Poster
- The final decision to accept or reject the submitted abstracts will be made by the Congress Chair.
- The presentation language and the abstract body must be the same language.
|
Type of Presentation
|
Abstract Title
|
Abstract Body
|
Authors
|
Affiliations
|
|
Oral
|
English
|
English
|
English
|
English
|
|
Poster
|
Category
For each category, select the one most suitable for your presentation.
|
[A]
|
| A01 |
Plant viruses |
| A02 |
Insect viruses |
| A03 |
Adenoviridae |
| A04 |
Asfarviridae |
| A05 |
Herpesvirales |
| A06 |
Papillomaviridae |
| A07 |
Polyomaviridae |
| A08 |
Poxviridae |
| A09 |
Parvoviridae |
| A10 |
Hepadnaviridae |
| A11 |
Retroviridae (Lentivirus) |
| A12 |
Retroviridae (except for Lentivirus) |
| A13 |
Reovirales |
| A14 |
Bornaviridae |
| A15 |
Filoviridae |
| A16 |
Paramyxoviridae |
| A17 |
Pneumoviridae |
| A18 |
Rhabdoviridae |
| A19 |
Arenaviridae |
| A20 |
Hantaviridae |
| A21 |
Nairoviridae |
| A22 |
Peribunyaviridae |
| A23 |
Phenuiviridae |
| A24 |
Kolmioviridae |
| A25 |
Orthomyxoviridae |
| A26 |
Astroviridae |
| A27 |
Caliciviridae |
| A28 |
Coronaviridae (SARS-CoV-2) |
| A29 |
Coronaviridae (except for SARS-CoV-2) |
| A30 |
Flaviviridae (Hepacivirus) |
| A31 |
Flaviviridae (except for Hepacivirus) |
| A32 |
Hepeviridae |
| A33 |
Matonaviridae |
| A34 |
Togaviridae |
| A35 |
Picornaviridae |
| A36 |
Prion |
| A37 |
Viroid |
| A38 |
Fungal/algal viruses |
| A39 |
Phage |
| A40 |
Others |
|
[B]
|
| B01 |
Structure |
| B02 |
Virus entry |
| B03 |
Genome and gene expression |
| B04 |
Assembly and release |
| B05 |
Replication of genome |
| B06 |
Viral spread and transmission |
| B07 |
Pathogenesis |
| B08 |
Oncogenesis |
| B09 |
Epidemiology |
| B10 |
Diversity and evolution |
| B11 |
Immunity |
| B12 |
Vaccines |
| B13 |
Antivirals |
| B14 |
Clinical medicine |
| B15 |
Gene therapy and viral vectors |
| B16 |
Data analysis and mathematical model |
| B17 |
Others |
Important Notice
- It is not permitted to submit the same abstract as one previously published in scientific journals.
- One abstract will be accepted per presenter (first author).
- Co-authors are eligible to submit more than one abstract.
- Only one abstract will be accepted when the abstracts from the same group are considered as one presentation.
- Please include the latest research result.
- The following abstracts will not be accepted: aim of study is not clear, irrelevant replication research, containing significant errors, gap between experiment and conclusion, and lack of moral consideration, etc.
Submitting Abstracts
- Please read the instructions carefully before submission.
- When you submit your abstract, please click on “Submit” button on the bottom of this page.
- After registration, a confirmation email of your abstract submission will be sent to your registered e-mail address. Please refer to this abstract number in all correspondence regarding the abstract.
- When you wish to confirm or correct your abstracts, please click on “View / Edit” button and login with ID and Password.
- All notices（Acceptance/Rejection, Adoption）will be sent to First Author by E-mail.
Abstract should be briefly summarized in the following order; Background, Materials and Methods, Results, and Discussion.
|
Abstract title
|
Limited to 140 characters
|
|
Presenting Author/ Co-authors
|
Limited to 20 authors
|
|
Institutions
|
Limited to 10 institutions
|
|
Abstract text
|
Limited to 2,000 characters
|
Notification of acceptance
- The program committee is responsible for reviewing all abstracts and deciding presentation style and time. If you have not received an e-mail notification, please contact the meeting secretariat.
- Notification regarding acceptance or rejection will be sent to the submitting authors’e-mail address by the end of July, 2025.
For inquiries
- Secretariat Office of the 72nd Annual Meeting of the Japanese Society for Virology
- C/O Convention Linkage, Inc.
- Asahiseimei Bldg., 3-32-20 Sakae, Naka-ku, Nagoya, 460-0008 Japan
- TEL: +81-52-262-5070 / FAX: +81-52-262-5084
- E-mail: jsv72@c-linkage.co.jp
